Progression of aortic valve stenosis is associated with bone remodelling and secondary hyperparathyroidism in elderly patients - The COFRASA study

European Heart Journal

Volumn 34, Issue 25, 2013, Pages 1915-1922

  Hekimian, Guillaume ^a   Boutten, Anne ^a   Flamant, Martin ^a   Duval, Xavier ^a   Dehoux, Monique ^a   Benessiano, Joelle ^a   Huart, Virginie ^a   Dupré, Thierry ^a   Berjeb, Nadia ^a   Tubach, Florence ^a   Iung, Bernard ^a   Vahanian, Alec ^a   Messika Zeitoun, David ^a,b  

^a BICHAT HOSPITAL   (France)

^b INSERM   (France)

Author keywords

Aortic stenosis; Bone remodelling; Calcium phosphorus metabolism

Indexed keywords

25 HYDROXYVITAMIN D; CALCIUM; CARBOXY TERMINAL TELOPEPTIDE; CREATININE; OSTEOCALCIN; PARATHYROID HORMONE; PHOSPHORUS; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; COLLAGEN TYPE 1; COLLAGEN TYPE I TRIMERIC CROSS-LINKED PEPTIDE; PEPTIDE; VITAMIN D;

AGED; AORTA VALVE STENOSIS; ARTICLE; BLOOD SAMPLING; BODY MASS; BONE MASS; BONE METABOLISM; BONE REMODELING; CALCIUM BLOOD LEVEL; CALCIUM METABOLISM; CARDIOVASCULAR RISK; CREATININE BLOOD LEVEL; DISEASE ASSOCIATION; DISEASE COURSE; ECHOCARDIOGRAPHY; FEMALE; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN TISSUE; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PHYSICAL EXAMINATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SECONDARY HYPERPARATHYROIDISM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WAIST CIRCUMFERENCE; ANALOGS AND DERIVATIVES; BLOOD; CLINICAL TRIAL; COMPLICATION; HYPERPARATHYROIDISM, SECONDARY; METABOLISM; PHYSIOLOGY;

AGED; AORTIC VALVE STENOSIS; BIOLOGICAL MARKERS; BONE REMODELING; CALCIUM; COLLAGEN TYPE I; CREATININE; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; MALE; OSTEOCALCIN; PARATHYROID HORMONE; PEPTIDES; PHOSPHORUS; PROSPECTIVE STUDIES; VITAMIN D;

EID: 84880230568     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehs450     Document Type: Article

References (39)

1. Iung B, Baron G, Butchart EG, Delahaye F, Gohlke-Barwolf C, Levang OW, Tornos P, Vanoverschelde JL, Vermeer F, Boersma E, Ravaud P, Vahanian A. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003;24:1231-1243.
2. Messika-Zeitoun D, Bielak LF, Peyser PA, Sheedy PF, Turner ST, Nkomo VT, Breen JF, Maalouf J, Scott C, Tajik AJ, Enriquez-Sarano M. Aortic valve calcification: determinants and progression in the population. Arterioscler Thromb Vasc Biol 2007;27:642-648.
3. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic-valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999;341:142-147.
4. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, Kitzman DW, Otto CM. Clinical factors associated with calcific aortic valve disease. Cardiovascular health study. J Am Coll Cardiol 1997;29:630-634.
5. O'Brien KD, Kuusisto J, Reichenbach DD, Ferguson M, Giachelli C, Alpers CE, Otto CM. Osteopontin is expressed in human aortic valvular lesions. Circulation 1995;92:2163-2168.
6. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994;90:844-853.
7. Cowell SJ, Newby DE, Prescott RJ, Bloomfield P, Reid J, Northridge DB, Boon NA. A randomized trial of intensive lipid-lowering therapy in calcific aortic stenosis. N Engl J Med 2005;352:2389-2397.
8. Rossebo AB, Pedersen TR, Boman K, Brudi P, Chambers JB, Egstrup K, Gerdts E, Gohlke-Barwolf C, Holme I, Kesaniemi YA, Malbecq W, Nienaber CA, Ray S, Skjaerpe T, Wachtell K, Willenheimer R. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis. N Engl J Med 2008;359:1343-1356.
9. Chan KL, Teo K, Dumesnil JG, Ni A, Tam J. Effect of Lipid lowering with rosuvas-tatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial. Circulation 2010;121:306-314.
10. Mohler ER 3rd, Gannon F, Reynolds C, Zimmerman R, Keane MG, Kaplan FS. Bone formation and inflammation in cardiac valves. Circulation 2001;103: 1522-1528.
11. Rajamannan NM, Subramaniam M, Rickard D, Stock SR, Donovan J, Springett M, Orszulak T, Fullerton DA, Tajik AJ, Bonow RO, Spelsberg T. Human aortic valve calcification is associated with an osteoblast phenotype. Circulation 2003;107: 2181-2184.
12. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001;85:635-638.
13. Schmitz F, Ewering S, Zerres K, Klomfass S, Hoffmann R, Ortlepp JR. Parathyroid hormone gene variant and calcific aortic stenosis. J Heart Valve Dis 2009;18: 262-267.
14. Aksoy Y, Yagmur C, Tekin GO, Yagmur J, Topal E, Kekilli E, Turhan H, Kosar F, Yetkin E. Aortic valve calcification: association with bone mineral density and cardiovascular risk factors. Coron Artery Dis 2005;16:379-383.
15. Skolnick AH, Osranek M, Formica P, Kronzon I. Osteoporosis treatment and progression of aortic stenosis. Am J Cardiol 2009;104:122-124.
16. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
17. Levey AS, Eckardt KU, Tsukamoto Y, Levin A, Coresh J, Rossert J, De Zeeuw D, Hostetter TH, Lameire N, Eknoyan G. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 2005;67:2089-2100.
18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatin-ine. Nephron 1976;16:31-41.
19. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, Van Lente F. Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 2007;53:766-772.
20. Awan Z, Alwaili K, Alshahrani A, Langsetmo L, Goltzman D, Genest J. Calcium homeostasis and skeletal integrity in individuals with familial hypercholesterolemia and aortic calcification. Clin Chem 2010;56:1599-1607.
21. Zittermann A. Vitamin D and disease prevention with special reference to cardiovascular disease. Prog Biophys Mol Biol 2006;92:39-48.
22. Baumgartner H, Hung J, Bermejo J, Chambers JB, Evangelista A, Griffin BP, Iung B, Otto CM, Pellikka PA, Quinones M. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009; 22:1-23.
23. Cueff C, Lepage L, Boutron I, Leye M, Detaint D, Hyafil F, Brochet E, Iung B, Vahanian A, Messika-Zeitoun D. Usefulness of the right parasternal view and non-imaging continuous-wave Doppler transducer for the evaluation of the severity of aortic stenosis in the modern area. Eur J Echocardiogr 2009;10:420-424.
24. Mohler ER 3rd, Adam LP, McClelland P, Graham L, Hathaway DR. Detection of osteopontin in calcified human aortic valves. Arterioscler Thromb Vasc Biol 1997;17: 547-552.
25. Rajamannan NM, Evans FJ, Aikawa E, Grande-Allen KJ, Heistad DD, Masters KS, Mathieu P, O'Brien K, Otto CM, Schoen FJ, Simmons G, Towler D, Yoganathan A. National Heart, Lung and Blood Institute (NHLBI) Working Group on Calcific Aotic Stenosis. http://www.nhlbi.nih.gov/meetings/workshops/cas.htm. (2010).
26. Sambrook P, Cooper C. Osteoporosis. Lancet 2006;367:2010-2018.
27. Raisz LG. Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 2005;115:3318-3325.
28. Herrmann M, Seibel MJ. The amino-and carboxyterminal cross-linked telopep-tides of collagen type I, NTX-I and CTX-I: a comparative review. Clin Chim Acta 2008;393:57-75.
29. Charles P, Poser JW, Mosekilde L, Jensen FT. Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest 1985;76:2254-2258.
30. Maher ER, Young G, Smyth-Walsh B, Pugh S, Curtis JR. Aortic and mitral valve calcification in patients with end-stage renal disease. Lancet 1987;2:875-877.
31. Akat K, Kaden JJ, Schmitz F, Ewering S, Anton A, Klomfass S, Hoffmann R, Ortlepp JR. Calcium metabolism in adults with severe aortic valve stenosis and preserved renal function. Am J Cardiol 2010;105:862-864.
32. Linhartova K, Veselka J, Sterbakova G, Racek J, Topolcan O, Cerbak R. Parathyroid hormone and vitamin D levels are independently associated with calcific aortic stenosis. Circ J 2008;72:245-250.
33. Hjortnaes J, Butcher J, Figueiredo JL, Riccio M, Kohler RH, Kozloff KM, Weissleder R, Aikawa E. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J 2010;31: 1975-1984.
34. Elmariah S, Delaney JA, O'Brien KD, Budoff MJ, Vogel-Claussen J, Fuster V, Kronmal RA, Halperin JL. Bisphosphonate use and prevalence of valvular and vascular calcification in women MESA (the multi-ethnic study of atherosclerosis). J Am Coll Cardiol 2010;56:1752-1759.
35. Aksoy O, Cam A, Goel SS, Houghtaling PL, Williams S, Ruiz-Rodriguez E, Menon V, Kapadia SR, Tuzcu EM, Blackstone EH, Griffin BP. Do bisphosphonates slow the progression of aortic stenosis? J Am Coll Cardiol 2012;59:1452-1459.
36. Sverdlov AL, Ngo DT, Chan WP, Chirkov YY, Gersh BJ, McNeil JJ, Horowitz JD. Determinants of aortic sclerosis progression: implications regarding impairment of nitric oxide signalling and potential therapeutics. Eur Heart J 2012;19: 2419-2425.
37. Vahanian A, Baumgartner H, Bax J, Butchart E, Dion R, Filippatos G, Flachskampf F, Hall R, Iung B, Kasprzak J, Nataf P, Tornos P, Torracca L, Wenink A, Priori SG, Blanc JJ, Budaj A, Camm J, Dean V, Deckers J, Dickstein K, Lekakis J, McGregor K, Metra M, Morais J, Osterspey A, Tamargo J, Zamorano JL, Angelini A, Antunes M, Fernandez MA, Gohlke-Baerwolf C, Habib G, McMurray J, Otto C, Pierard L, Pomar JL, Prendergast B, Rosenhek R, Uva MS. Guidelines on the management of valvular heart disease: the task force on the management of valvular heart disease of the European Society of Cardiology. Eur Heart J 2007;28:230-268.
38. Garcia P, Schwenzer S, Slotta JE, Scheuer C, Tami AE, Holstein JH, Histing T, Burkhardt M, Pohlemann T, Menger MD. Inhibition of angiotensin-converting enzyme stimulates fracture healing and periosteal callus formation-role of a local renin-angiotensin system. Br J Pharmacol 2010;159:1672-1680.
39. Kaneko K, Ito M, Fumoto T, Fukuhara R, Ishida J, Fukamizu A, Ikeda K. Physiological function of the angiotensin AT1a receptor in bone remodeling. J Bone Miner Res 2011;26:2959-2966.